Clinical Trials Update: June 15, 2005
Urinary Incontinence Prostate Cancer High Cholesterol (Hyperlipidemia)
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Millions of American women experience bladder leakage during everyday activities. Are you one of them? If you are a woman and are between the ages of 18 and 65, experience involuntary leakage of urine on exertion, sneezing or coughing at least seven times a week, and have had this problem for more than three months, you may be eligible for this research study of an investigational medication. Research site located in Portland, Ore.
GVAX prostate cancer vaccine is an investigational product in Phase 3 clinical development for patients with advanced-stage, hormone-refractory prostate cancer. This study is to compare the duration of survival between GVAX and chemotherapy treatments. Participants must have confirmed diagnosis of or clinical history consistent with adenocarcinoma of the prostate, prostate cancer deemed to be unresponsive or refractory to hormone therapy, detectable metastases (cancer that has spread outside the prostate) and two consecutive rising PSA values obtained at least 4-6 weeks after discontinuation of antiandrogen therapy. Research sites located in Arkansas, Arizona, and California.
High Cholesterol (Hyperlipidemia)
Are you currently taking medicine to treat high cholesterol? If so, and you are at least 18 years old, you may qualify for a medical research study to test a marketed medication to treat high cholesterol in an investigational use. Participants in the study will receive study medication (some patients will receive placebo), study related physician visits, and lab work. Research site located in Las Vegas, Nev.
Copyright 2005 CenterWatch. All rights reserved.